Introduction
The suspected link between Helicobacter pylori infection and gastric cancer is supported by histopathological, [1] [2] [3] [4] and epidemiological studies. [5] [6] [7] [8] [9] Some of these data led the International Agency for Research on Cancer to classify H pylori as a class I carcinogen in 1994. 10 Some authors feel, however, that this conclusion has been based on simple association rather than a true causal link, and they dispute the quality of epidemiological evidence in its favour. 11 One of the main criticisms that has been raised concerns the paradoxically low gastric cancer rates found in some populations with very high rates of infection. 12 Another arises from the low incidence of gastric cancer among patients with duodenal ulcer, a disease known to be caused by H pylori infection. 13 14 Many hypotheses have been advanced to explain these discrepancies. The genetic makeup of the host, diet, immunological status, diVerences between various strains of H pylori, 12 15-19 and age at the time of infection 20 have all been proposed as factors potentially capable of influencing the outcome of H pylori infection in diVerent geographical areas and in diVerent individuals. From the biological point of view, malignancy is known to be the result of an accumulation of genetic alterations and mutations that are responsible for the diVerent phenotypes within the carcinogenic cascade.
Up to now there has been no evidence that H pylori induces any sort of irreversible DNA damage, and there are no experimental models of H pylori related gastric carcinogenesis. However, it is clear that the organism is capable of modifying epithelial cell turnover within gastric glands. Disturbances in cell turnover in the gastrointestinal tract are believed to predispose to cancer development, and, until recently, these changes were considered to be a marker of increased cancer risk. 21 The purpose of this article is to review current thinking on the importance of these changes.
Helicobacter pylori infection and epithelial cell turnover in gastric glands
There is strong evidence that H pylori infection alters the kinetic pattern of gastric glandular epithelium. In the glands of the gastric mucosa, as in the other segments of the digestive tract, cell renewal is rapid. Thus a delicate balance among all factors influencing this process is needed to maintain a normal tissue volume in healthy people. The key points of this homoeostatic process are cell proliferation and programmed cell death, or apoptosis. Both are highly regulated phenomena that are essential for remodelling tissues during development, maintaining tissue homoeostasis and repair following injury, and both can be modulated (that is, promoted or inhibited) by several factors. Cell proliferation and apoptosis may be reversible phenomena, though in some casesthat is, neoplastic tissues, they are not. The proliferative zone of the gastric gland-that is, the site of stem cells, is located in the neck and isthmus (fig 1) . As they mature, these cells normally migrate towards the two extremities of the gland: mucus cells moving upward into the foveolar zone; parietal cells, together with a limited number of mucus cells, shifting downwards into the base of the gland. During this bi-directional migration, the cells diVerentiate, gradually lose their replicative capacity and eventually die. In fact, proliferating cells are rarely found in the intermediate zone and apex of the pits or at the bottom of glands. 22 23 Many investigators have demonstrated increased cell proliferation in gastric glands associated with H pylori infection. [24] [25] [26] [27] [28] [29] The kinetic pattern usually observed in these cases is represented by an actual increase in the total number of proliferating epithelial cells within the gland, together with an abnormal distribution of the cycling cells along the length of the gland. This situation translates into an unusually large number of proliferating (and therefore, undifferentiated) cells at the apex of the pits. 26 28 29 Table 1 shows the results of a proliferation study we conducted using bromodeoxyuridine immunohistochemical analysis of antral biopsy specimens from patients with H pylori related gastritis and non-infected controls. The total labelling indexes (LI) and the LIs for each of the five compartments into which gastric pits were divided confirmed that in the H pylori infected patients there is an overall increase in epithelial cell proliferation within the gastric foveolae, with an upward shift of proliferating cells toward the surface. 30 These changes are thought to be caused by an increase in the mucosal content of ammonia, known to be a strong stimulus of cell proliferation, 31 32 33 provoked by the bacterium itself. H pylori infection associated hypergastrinaemia is also believed to play a role in increasing epithelial cell turnover. 31 Whether the altered cell proliferation is also related to the inflammatory infiltrate is controversial. Using semi-quantitative scoring systems to estimate the intensity of inflammation, various investigators have reached diVerent conclusions. 23 26 34 However, when cell proliferation figures were compared with mucosal inflammatory cell counts using computer aided image analysis, 35 36 a positive correlation emerged between total labelling indexes and both polymorphonuclear and mononuclear cell densities (fig 2) . 37 This finding seems to support a role for inflammation in determining the alterations in foveolar cell kinetics seen during gastric H pylori infection. The inflammatory mechanism underlying the bacterium's enhancement of epithelial cell turnover may include mucosal production of tumour necrosis factor , interleukin 1 and interleukin 6, all of which have been shown to influence epithelial cell proliferation. 38 It has also been shown that increased generation of free radicals occurs during H pylori infection, 38 39 and these are believed to interact with the cells in the proliferative compartment to increase cell proliferation. 23 Moreover, inflammation during H pylori infection is accompanied by a decrease in the mucosal content of vitamin C, 40 which is an important chemical defence against oxidative DNA damage. Epithelial hyperproliferation in H pylori associated chronic superficial gastritis returns to normal after the infection has been eradicated 27 41 42 and remains normal unless reinfection occurs. 23 The hyperproliferative state provoked by the infection thus seems to be reversible.
Epithelial kinetic patterns of glands along the gastrointestinal tract can be easily modulated by several factors. Hyperproliferation in the colonic mucosa has-for example, been successfully diminished by modifying the mucosal content and quality of polyunsaturated fatty acids. 43 44 Similar improvement has been achieved in the gastric mucosa with betacarotene supplementation. 45 During progression from chronic superficial gastritis to subsequent phases of Correa's cascade (chronic atrophic gastritis, intestinal metaplasia, dysplasia, cancer), 46 this reversibility seems to be lost. In the pre-helicobacter era, it was already known that epithelial hyperproliferation occurs in both atrophic and metaplastic glands, 47 48 and this finding was later confirmed in association with H pylori infection. 28 29 It has been shown recently that the development of atrophic gastritis and intestinal metaplasia are strongly related to H pylori infection, 49 but the proliferative pattern of metaplastic epithelium does not seem to be related to H pylori status. 29 Recently Ierardi et al observed that in patients with chronic active H pylori gastritis, 42 proliferation in the gastric foveolae returns to normal after the infection has been eliminated, but normalisation is not observed in metaplastic (complete or incomplete) cells. This finding indicates that control of cell proliferation is somehow lost during the progression from chronic gastritis to intermediate steps of gastric carcinogenesis. Intestinal metaplasia might thus represent the phenotypic expression of the true initiating phase of the carcinogenic process. The genetic mutations underlying these crucial changes in the regulation of proliferation are still unknown. Progression from chronic active H pylori gastritis to chronic atrophic gastritis seems to be related to cagA positivity. 19 Very few studies have focused on All results are expressed as median (range). Subjects with H pylori positive gastritis had a significantly higher total labelling index (LI) compared with H pylori negative controls (*p<0.01, MannWhitney U test). Moreover, when gastric pits were divided into five longitudinal compartments (base compartment 5 to apex compartment 1), cell proliferation was significantly increased in the upper part of the pits in H pylori positive subjects ( †p<0.005, Mann-Whitney U test).
the influence of diVerent H pylori strains on gastric epithelial cell proliferation, but the results that have emerged seem to be somewhat contradictory. 50 51 This issue clearly requires further investigation.
Apart from cell proliferation studies, attention has recently been focused on the role of cell death in the development and progression of tumours. In the gastrointestinal tract (as elsewhere), homoeostasis during the renewal of tissues is a balance between cell production and cell loss. There seem to be two distinct types of cell death: necrosis and apoptosis. 52 While the former is a pathological event resulting from acute cellular injury, apoptosis is a genetically encoded, physiological, active and irreversible process that plays a major role in tissue development and renewal, and alterations in this process are believed to be involved in the pathogenesis of many human diseases. 53 Apoptosis is, in fact, regulated by a variety of intra-and extracellular signals that act either to suppress or enhance the expression of specific cellular genes. 53 The genetic programmes involved in regulation of apoptosis seem to occur in distinctly diVerent stages, 54 each modulated by a specific set of genes identified as ced (cell death defective), as seen in studies of the nematode Caenorhabditis elegans. 55 56 bcl-2, a human proto-oncogene, which is highly homologous to ced-9 of C elegans, 57 is known to play an important role in regulation of apoptosis; it encodes a 26 kDa protein and is localised to mitochondria, endoplasmic reticulum and the perinuclear membrane. Bcl-2 protein is a part of a large family of proteins encoded by specific genes belonging to the so called bcl-2 family. Some of these proteins (bcl-2 and bcl-xL) support survival, 58 whereas others (bax, bad, bcl-x5) are apoptosis inducers. [59] [60] [61] Recently, overexpression of bcl-2 with abnormal distribution of apoptotic cells along the glands, which are usually found at the extremities of normal gastric glands, 62 has been described in both intestinal metaplasia and gastric dysplasia. 63 64 Altered distribution of apoptotic cells, particularly their unusual presence in the regenerative zone of gastric glands, has also been confirmed by using a specific immunohistochemical technique (TUNEL, see later). 65 66 These findings indicate that defective control of the process of apoptosis already occurs in the early stages of gastric carcinogenesis. 67 The p53 gene is also known to be heavily implicated in the life and death processes of human cells. It is currently believed that the function of p53 takes place through two main mechanisms: cell cycle arrest and stimulation of apoptosis. 68 69 This stimulation is demonstrated by the fact that the apoptotic response to radiation and other DNA damaging agents is reduced in the absence of p53. [70] [71] [72] [73] The current opinion is that in physiological conditions p53 is activated when DNA damage occurs. At this point diVerent factors induce cells to decide to enter p53 mediated cell cycle arrest or the apoptotic pathway. The factors influencing the decision of a cell to select one of these two pathways are not fully known. It seems that in the case of unstable genomes, activation of oncogenes forcing the cells into a replicative cycle or when survival factors of cells are limited, the p53 mediated apoptosis prevails. 69 The p53 gene is mutated in a large percentage of cancers. Immunohistochemically demonstrable overexpression of p53 is regarded as a marker of the accumulation of a stable mutant p53 protein within the cells and it has been found in a high percentage of advanced gastric cancers. 74 75 Detectable overexpression of p53 protein 76 as well as p53 gene mutations 77 have been also found in early gastric carcinomas. Furthermore, alterations in the p53 gene have been described in both intestinal metaplasia and gastric dysplasia. 78 As far as the influence of H pylori infection on gastric epithelial apoptosis is concerned, diVerent groups have investigated this phenomenon both in experimental models and in vivo studies. Moss et al, 79 using the TdTmediated dUTP-biotin nick end labelling (TUNEL) technique, found that gastric epithelial apoptosis was clearly enhanced in duodenal ulcer patients with H pylori infection compared with H pylori negative controls. Similar findings have been reported by others. 80 81 We have recently investigated epithelial apoptosis in antral gastric mucosa of patients with non-ulcer dyspepsia with and without H pylori infection, using the same technical approach. 82 In our study the presence of H pylori infection was not associated with any significant changes in gastric epithelial apoptosis and there was wide variability in the apoptotic indexes of both H pylori positive and H pylori negative groups (fig 3) . This discrepancy may be explained by additional data recently published by Peek et al, 83 who found that patients infected with cagA positive H pylori strains had apoptotic indexes significantly lower than patients with cagA negative strains. When these subgroups were combined and compared with a non-infected control group, no diVerence in the mean apoptotic indexes was observed. So it is possible that the similarity of the apoptotic indexes found in H pylori positive and H pylori negative patients in our study might reflect the cagA+/cagA− makeup of the former group (we did not attempt to classify the strains in our patients). Conversely, the results of in vitro studies seem to be more consistent, indicating that apoptosis is indeed stimulated by H pylori regardless of whether the strain is cytotoxic. [84] [85] [86] [87] [88] [89] [90] However, it must be emphasised that data on apoptosis in cultured cells may not always be applicable to the in vivo situation. 91 A decrease in apoptosis has been described after eradication of H pylori infection. 79 92 93 As for the mechanisms underlying the possible eVects of H pylori on gastric epithelial apoptosis, several recent findings may be relevant. For example, Kuck et al have reported that H pylori up-regulates the expression of the CD95 (or apo-1FAS) receptor, 87 which plays an important role in initiating apoptosis. In fact, the enhanced CD95 expression observed in this study was associated with increased rates of apoptosis in gastric epithelial cell lines. The inhibitory eVect on human gastric apoptosis provoked by cytotoxic strains of H pylori has recently been attributed to the activation of NF-B, a transcription factor whose enhancement seems to reduce the rate of apoptosis. 83 94 95 However, there is also evidence that apoptosis in AGS gastric epithelial cells is an NF-B independent phenomenon. 90 Future studies on the genes that regulate apoptosis in humans, such as p53 and bcl-2, 53 will probably provide more information on the actual eVect of H pylori infection on epithelial apoptosis. Recently, overexpression of bax and bak proteins encoded by the two pro-apoptotic members of the bcl-2 gene family, together with moderate suppression of bcl-2 itself, has been associated with H pylori induced apoptosis in the AGS gastric epithelial cell line.
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Conclusions
Epithelial cell proliferation and altered distribution of cycling cells within gastric glands are a common feature of chronic superficial gastritis caused by H pylori infection. This phenomenon seems to be reversible as successful eradication of the infection is followed by persistent normalisation of cell kinetics. Because of its reversibility, gastric epithelial cell hyperproliferation in chronic superficial gastritis cannot be regarded as a marker of tumour initiation. Certainly the persistence of this altered cell turnover pattern, with proliferating cells located in the superficial zone of the gastric pits, increases the risk of DNA damage by endogenous and exogenous carcinogens. In this sense the enhanced cell proliferation in chronic active gastritis represents only a very generic increase in the risk of developing cancer. Other co-factors are needed to induce the genetic changes underlying premalignant and malignant phenotypes. Thus, the hyperproliferation associated with chronic active H pylori gastritis represents a sort of "driver" for carcinogens. 12 Hyperproliferation within atrophic and metaplastic glands seems to have a diVerent significance and to express a diVerent level of risk. In this case the phenomenon seems to have escaped the reach of normal control mechanisms, persisting even after the apparent stimulus (that is, the infection) has been eradicated. Apoptosis of gastric epithelial cells seems to be enhanced by H pylori as shown by in vitro experiments, whereas in vivo studies have not produced conclusive results so far. It seems that cagA status may influence the in vivo eVect of H pylori infection on epithelial apoptosis in gastric glands. 83 There is some evidence that in vitro H pylori induced apoptosis is associated with diVerent expressions of pro-and anti-apoptotic genes of the bcl-2 family, but further study is needed to clarify how the molecular events of the apoptotic pathway of gastric epithelial cells can be aVected by H pylori infection.
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